They will be joined by Public Health England’s Dr Campbell Murdoch, Professor Richard Welbourn, a consultant bariatric surgeon at the Taunton and Somerset NHS Foundation Trust and patient Mark Hancock who has type 2 diabetes.

The aim of the meeting, on Wednesday, June 27, is to discuss the longer-term impact and effectiveness of bariatric surgery and new weight management treatments con those with type 2 diabetes.

Academics, specialists, healthcare professionals and people with diabetes will also discuss the supporting evidence, challenges and opportunities in relation to the current type 2 diabetes treatments and therapies that are currently being advised.